New Search

Your search found 2 records, sorted by year and then date of acquisition.

1. Comparative Effectiveness of Extended-Release Naltrexone Versus Buprenorphine-Naloxone for Opioid Relapse Prevention (X:BOT): A Multicentre, Open-Label, Randomised Controlled Trial. doc type doc type
  Lee, Joshua D. ; Nunes, Edward V. ; Novo, Patricia ; Bachrach, Ken ; Bailey, Genie L. ; Bhatt, Snehal ; Farkas, Sarah ; Fishman, Marc J. ; Gauthier, Phoebe ; Hodgkins, Candace C. ; King, Jacquie ; Lindblad, Robert ; Liu, David S. ; Matthews, Abigail G. ; May, Jeanine ; Peavy, K. Michelle ; Ross, Stephen ; Salazar, Dagmar ; Schkolnik, Paul ; Shmueli-Blumberg, Dikla ; Stablein, Don ; Subramaniam, Geetha A. ; Rotrosen, John
 The Lancet 2017 (in press). [doi: 10.1016/S0140-6736(17)32812-X].
 
2. Ethical and Clinical Safety Considerations in the Design of an Effectiveness Trial: A Comparison of Buprenorphine Versus Naltrexone Treatment for Opioid Dependence. doc type
  Nunes, Edward V. ; Lee, Joshua D. ; Sisti, Dominic ; Segal, Andrea ; Caplan, Arthur ; Fishman, Marc J. ; Bailey, Genie L. ; Brigham, Gregory S. ; Novo, Patricia ; Farkas, Sarah ; Rotrosen, John
 Contemporary Clinical Trials 2016;51:34-43. [doi: 10.1016/j.cct.2016.09.006].